Gilead Sciences reported $6.22B in Sales Revenues for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 13959M 949M
Acorda Therapeutics ACOR:US $ 31.78M 2.92M
Alexion Pharmaceuticals ALXN:US $ 1636.5M 44.7M
ALKERMES ALKS:US $ 303.72M 52.29M
Alnylam Pharmaceuticals ALNY:US $ 220.55M 42.99M
Amgen AMGN:US $ 6526M 625M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Biogen BIIB:US $ 2775M 81M
Biomarin Pharmaceutical BMRN:US $ 501.69M 15.66M
Bluebird Bio BLUE:US $ 7.47M 5.32M
Bristol Myers Squibb BMY:US $ 11703M 630M
Coherus Biosciences CHRS:US $ 87.64M 4.61M
Eli Lilly And LLY:US $ 6740.1M 65.5M
Gilead Sciences GILD:US $ 6217M 206M
GlaxoSmithKline GSK:LN 8092M 674M
Glaxosmithkline GSK:US $ 8092M 674M
Intercept Pharmaceuticals ICPT:US $ 96.58M 14.92M
Johnson & Johnson JNJ:US $ 23312M 991M
Merk MRK:US $ 11402M 678M
Moderna Inc MRNA:US 4.35B 2.42B
Neurocrine Biosciences NBIX:US $ 288.9M 52.3M
Novartis NOVN:VX SF 13294M 600M
Pfizer PFE:US $ 18977M 4395M
Ptc Therapeutics PTCT:US $ 116.68M 1.27M
Puma Biotechnology PBYI:US $ 53.38M 44.78M
Regeneron Pharmaceuticals REGN:US $ 5138.5M 2609.8M
Sangamo Biosciences SGMO:US $ 27.87M 1.59M
Sarepta Therapeutics SRPT:US $ 164.09M 17.16M
Teva Pharmaceutical Industries TEVA:US $ 3910M 72M
United Therapeutics UTHR:US $ 446.5M 67.4M
Vertex Pharmaceuticals VRTX:US $ 1793.37M 69.06M
YTE INCY:US $ 705.71M 100.99M